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BACKGROUND: C-C motif Ligand 7 (CCL7) has been reported to be associated with asthma severity in humans. Cynomolgus macaques 
(Macaca fascicularis; Mf) are often used as animal model 
of asthma but little is known about Mf genetic profile 
such as polymorphism. Our aim was to identify CCL7 
polymorphism in Mf as a potential surrogate marker for 
identification of allergen responsiveness in the Mf model of 
asthma. 
METHODS: Real-time PCR was performed on archive of 
bronchoalveolar fluid samples previously collected from Mf 
that were exposed to allergen. Expression of CCL7 mRNA 
was evaluated, and sequencing technique was used to 
identify polymorphism in this gene.
RESULTS: The results showed that CCL7 expression did 
not differ between Mf, despite a trend of lower expression in 
Mf that exhibited high response to allergen. By direct DNA 
sequencing of CCL7, 10 sequence variants were identified; 
three in promoter region (-460 G/A, -459 A/G, -456 -/A ), 
two in exon 1 (9 A/G, 65 G/C), four in intron 1 (135 T/C, 
254 T/C, 420 T/C, 453 A/G), and one in intron 2 (1205 T/A). 
CONCLUSION: There was an association between Mf 
sensitivity to allergen with CCL7 promoter polymorphism 
at (-456 -/A). These results suggest that CCL7 may be 
a potential genetic marker to identify Mf sensitivity to 
allergen, which could be a useful tool to efficiently select 
for Mf model of asthma.
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Abstract
Introduction
Respiratory diseases including asthma are often complex 
polygenic disorders that manifest as the result of exposure 
of genetically susceptible individuals to airway reactive 
substances within their environments.(1) Asthma is 
a chronic disorder of the respiratory tract, in which a 
severe inflammation causes obstruction of the airflow, 
airway hyperresponsiveness to stimuli, bronchospasm and 
symptoms such as cough, wheezing, dyspnoea and chest 
tightness.(2) Asthma remains the most common respiratory 
disease both in developing and developed countries.(3,4) 
Study in families affected with asthma suggest several 
chromosome regions may contain potential candidate genes 
associated with the disease.(5,6)
 The nonhuman primate (NHP) is genetically, 
anatomically and immunologically similar to humans and 
represents a valuable model system for human airway 
disease.(7-9) Studies have reported the use of Mf in research 
of asthma drugs (10,11), but details on the model’s genetic 
background is limited. Even though Mf are spontaneously 
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responsive to allergen (12,13), the skin and airway 
responsiveness may vary between individuals (14), which 
could be important for study interpretation. 
 The pathogenesis of asthma has long been studied, and 
it was demonstrated that CC chemokines play an important 
role. They are a subfamily of chemokines containing 4 or 
6 cysteins. CC chemokines and their receptors contribute 
in facilitating leukocyte function, and hence, developing 
immune response15. Protein C-C motif Ligand 7 (CCL7), 
previously known as Monocyte Chemotactic Protein-3 
(MCP-3), is a secreted during inflammatory process of 
asthma. CCL7 is a member of C-C chemokine family located 
on chromosome 17q11.2-q12.(15) CCL7 polymorphisms in 
several sites in the human genome have been associated 
with asthma severity in certain populations.(16,17) 
Importantly, CCL7 expression was found high in asthmatic 
monkeys.(18,19) However, it is unknown if the nucleotide 
sequence profile of this gene is a determinant for allergen 
hypersentivity in monkeys.
 In this study, we identified mRNA expression and 
sequenced six regions of CCL7 gene in 8 adult Mfs. These 
animals were reported to exhibit different responses to 
Ascaris suum, a classic allergen used in asthma studies. 
The primary objective was to identify single nucleotide 
polymorphism (SNP) within the CCL7 gene in Mf as a 
potential genetic marker to identify allergen responsiveness. 
Methods
Samples
This research used archived bronchoalveolar lavage (BAL) 
fluid samples collected from Mf that were enrolled in an 
asthma study.(14) Briefly, the asthma study was performed 
in Primate Research Center at Bogor Agricultural University 
and PT. Bimana Indomedical following approval from the 
Institutional Animal Care and Use Committee (IACUC) 
with ethical approval No. PTBI IACUC 05-07-1R. The 
results have been reported wherein Mf showed differential 
skin and airway responses to A. suum, and were defined as 
high and low responders. High and low responders were 
Mf that showed asthma response following exposure to 
low and high dose of A. suum, respectively.(14) Here, we 
used 8 archive samples from both groups (n=4 from high 
responders and n=4 from low responders).
Gene Expression Of CCL7, CCR1, and CCR3
The isolation of mRNA from BALf samples was performed 
using the Qiagen RNAeasy mini kit (Qiagen, Hilden, 
Germany). The isolated mRNA concentration was measured 
using NanoDrop (Thermo Fisher, Waltham, Massachusetts, 
USA). A total of 0.7 ng/μL mRNA was used as a template 
for reverse transcription process. The cDNA synthesis  was 
performed with Superscript III RT enzyme from Invitrogen 
(Life Technology, Eugene, Oregon, USA) according 
to the company instructions. The molecular expression 
level of CCL7, CCR1, and CCR3 was evaluated using 
Realtime PCR technique (qRT-PCR). qRT-PCR was done 
using SsoFast™ EvaGreen® Supermix (Biorad, Hercules, 
California, USA) according to the company manual. The 
primer used is presented in Table 1. The qRT-PCR data 
were evaluated using delta Ct method using glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) as the reference 
gene, and statistical analysis was performed using SPSS 18 
(IBM Corporation, Armonk, New York, USA).
Polymerase Chain Reaction (PCR) and Sequencing
The same subset of BALf samples used for gene expression 
analysis was also used for sequencing purposes. DNA 
isolation from BALf was performed using DNeasy Blood 
and Tissue Kit Qiagen (Qiagen). Ampilification of 5 μL 
DNA was performed by Hotstart PCR technique using KAPA 
Hotstart Master Mix PCR (KAPA Biosystem, Wilmington, 
North Carolina, USA). The primers for CCL7 used in this 
study were amplified from promoter to terminator region 
(Figure 1) referred to prior publication 17 with modification 
(Table 2). The PCR technique was performed in Thermo 
cycler Applied Biosystem Perkin Elmer 9700 with program 
incubation 94oC for 5 minutes, 94oC denaturation for 30 
seconds, 60oC annealing for 30 seconds, extension of DNA 
at 72oC for 30 seconds, and post PCR 72oC for 5 minutes. The 
denaturation stage until the extension of the DNA strands 
Gene Forward (5’-3’) Reverse (5’-3’) Species
CCL7 GAGCTACAGAAGGACCACCAGT AAGTCCTGGACCCACTTCTG Human 17
CCR1 CTGGTTGGAAACATCCTGGT GGAAGCGTGAACAGGAAGAG Human 29
CCR3 GTGTTCACTGTGGGCCTCTT GTGACGAGGAAGAGCAGGTC Human 28
GAPDH CGGATTTGGTCGTATTGG TCAAAGGTGGAGGAGTGG Human 34
Table 1. Primer sequences used for RealTime PCR.
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was repeated 40 cycles. The PCR results were visualized 
by agarose gel electrophoresis 1.8% and read using GelDoc 
2000 (Biorad, Hercules, California, USA). DNA sequencing 
was performed at 1st BASE (1st BASE, Selangor, Malaysia). 
DNA sequencing results were analyzed using BioEdit 
program (Ibis Biosciences, Carlsbad, California, USA).(20) 
Analysis of sequencing results was carried out using Clustal 
W program of MEGA 5.2 (Pennsylvania State University, 
Pennsylvania, USA).(21) Analysis of haplotype was carried 
out using DnaSP program (Universitat de Barcelona, 
Barcelona, Spain).(22)
Promotor                         Intron 1                      Intron 2Exon 1                   Exon 2                  Exon 3
Ex-1F Ex-1R Ex-2F
Ex-2R
Pro-3F Ex-3R
Ex-2R
Pro-3R Int-1F Int-1R Ex-3F
Figure 1. Primer position in analysis of CCL7 SNPS in Mf. Mf covered the region of promoter (Pro-3F and Pro-3R), exon 1 (Ex-1F and 
Ex-1 R), exon 2 (Ex-2F and Ex-2 R), exon 3 (Ex-3 F and Ex-3 R), and  intron 1 (Int-1F and Int-1 R). Primers are indicated as arrows and 
the target region are indicated as block . 
Primer Region Amplicon Annealing Temperature Primer Sequence
MCP-3 pro-3 Promoter 613 55 F: TGGGTTTTAGAAAGCCACCAGG
R: GGGCAATGTGCTTCAAGGAGAA
MCP-3 ex-1 Exon 1 640 57 F: AAGTGCACCGGCTCAGCAGATT
R: TGCAGAGCTGCTGTTTCTGGAA
MCP-3 ex-2 Exon 2 584 57 F: CAAAGACACCGGACTTGGGACG
R: ATGCCTCAGGGATGGAGGAGGA
MCP-3 ex-3 Exon 3 534 58 F: AGACTTCAGTTCTTTTATCCTGG
R: TCCACCAAAATCCATGGAAGA
MCP-3 int-1 Intron 1 629 55 F: AGCAGAGTTTGGGATCGGGTGA
R: ACACATTACAGCTTCCGGGGA
MCP-3 int-2 Intron 1-terminater 1235 56 F: TTTGGGATCGGGTGATCAAAAA
R: AATCACTCTGAGAAAGGACAGGGT
Table 2. Primer sequence for SNP analysis CCL7 in Mf.
Results
The coding sequences of Mf CCL7 was  submitted to NCBI 
Genbank (MF062250).(23) The qRT-PCR results showed a 
trend of difference in the mRNA expression of CCL7 and 
its receptors between low and high responders. Figure 2 
shown gene expression of CCL7, CCR1, and CCR3 of high 
responder group were down regulated compared to low 
responder with fold change value as 0.217, 0.228, and 0.115, 
respectively. Although not statitically significant, there 
was a trend of higher CCL7 expression in low responders 
compared to high responders (p=0.081). Similar expression 
pattern was found on CCL7’s receptors with p-values of 
0.063 for CCR1 and 0.073 for CCR3. 
  DNA samples were evaluated to identify CCL7 
polymorphism. Our analysis indicated 4 areas in the CCL7 
gene that showed nucleotide sequence variation (Figure 
3); the promoter (-460 G/A, -459 A/G, -456 -/A ), exon 
1 (9 A/G, 65 G/C), intron 1 (135 T/C, 254 T/C, 420 T/C, 
453 A/G), and intron 2 (1205 T/A). Among those, the 
genetic variation in the promoter region was associated 
with reactivity phenotype wherein 3 polymorphic sites 
were found, which produced 4 haplotypes. One haplotype, 
particularly at position -456, was evident in animals that 
had low reactivity to allergen. The number of haplotypes 
and individual groupings based on these haplotypes are 
presented in Table 3.
Discussion
Our study showed an association between polymorphism 
of CCL7 promoter and Mf reactivity to asthma-inducing 
allergen, whereby a haplotype of -456 A/- was exclusive 
to low responders. Expression of CCL7 mRNA and its 
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Figure 2.  Level of mRNA expression for CCL7 and 
its receptors. No significant difference was observed 
although high responder Mf showed a trend of lower 
expression compared to low responder Mf for CCL7 
(p=0.08), CCR1 (p=0.06), and CCR3 (p=0.07). Values 
were means, error bars = SD.
Figure 3.  Gene map and SNPs position in CCL7 Mf. Coding exons are marked by red blocks and first base of translation site was denoted 
as nucleotide +1. Nucleotide position of the genes was indicated  with the number and the arrow was indicated position of SNPs. There are 
SNPs in Promoter (-460 G/A, -459 A/G, -456 -/A ), Exon 1 (9 A/G, 65 G/C), Intron 1 (135 T/C, 254 T/C, 420 T/C, 453 A/G), and Intron 
2 (1205 T/A).
receptors appeared to be higher in low responders group 
although they were not found to be statistically significant.
 Asthma studies involving Mf rarely take into 
consideration the genetic background of the model despite 
the fact that asthma is a polygenic disorder and that genetic 
polymorphism are commonly found in nonhuman primates 
more than in humans.(24,25) We have recently characterized 
CCL7 mRNA of Indonesian Mf.(23) To our knowledge, our 
study is the first to indicate that CCL7 polymorphism may 
determine Mf responsiveness to allergen and asthma. The 
grouping based on CCL7 promoter haplotype showed an 
interesting result as Haplotype I was found to be specific 
to monkeys in the low responder group. Research on 
association of SNPs in the gene encoding chemokine and 
asthma phenotype is a developing field. A study in the 
Korean population found CCL7 polymorphism in the 
promoter region although it was not associated with asthma 
severity.(17) In contrast, polymorphism within the CCL7 
promoter region was associated with atopic asthma in Indian 
population.(16) The association between asthma response 
and genetic variation also occurs in other chemokine-
related genes. Previous study reported a link between CCL2 
polymorphism and the nature of asthma response in families 
with asthma in Tunisia.(26) 
 CCL7 is one of the chemokines that plays a role in the 
pathophysiology of asthma. It has been reported that higher 
CCL7 expression was associated with an increase in the 
number of eosinophils in bronchial mucosa of individuals 
with asthma compared to healthy individuals.(17) In a 
microarray study of asthmatic monkeys, CCL7 was the 
gene with the highest expression.(18) Here, we performed 
a preliminary study with limited number of animals and 
found a trend of differential CCL7 expression between 
asthmatic monkeys of different reactivity to allergen. 
Although not statistically significant, the expression of 
CCL7 and its receptors showed a higher trend in the 
BALf of low responders compared to high responders. As 
the BALf samples were taken at 24 hours following the 
asthma episode induced by airway challenge, this result 
may indicate that the chemokine response could have 
occurred immediately in the high responders which caused 
the expression to have decreased by 24 hours. In contrast, 
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-460 -459 -456
 I A G A 4 Low responders
  II A G - 1 High responder
 III A A - 1 High responder
 IV G A - 2 High responders
8
Haplotype
Promoter Region
n
Total samples
Phenotype Remarks
Table 3.  Identified SNP in promoter regions and haplotypes.
low reactivity responders may have exhibited a slower 
chemokine response. It has been previously reported that 
the expression of CCL7 and other chemokines increased 
within 4 hours and decreased by 8 h post A. suum inhalation 
and was back to near base line  by 24 hours.(18) Since there 
was no BALf sample that represented an earlier timepoint 
(i.e., less than 24 hours post-allergen challenge), it is unclear 
whether low and high reactivity responders react differently 
during the acute phase of allergen inhalation. Alternatively, 
the result may be indicative of a compensatory mechanism 
that occurs with the high reactivity responders in their 
effort to decrease airway hyper-responsiveness. In non-
allergic mice, down regulation of CCL7 was found to 
reduce rhinovirus-induced airway hyper-reactivity.(27) 
Compensation is a relatively common mechanism during 
asthma response whereby in transgenic models of asthma, 
it has been reported that compensatory mechanisms such as 
those involving up regulation of G-protein or ion channels 
occur to attenuate airway responsiveness or smooth muscle 
contractility.(28,29) 
 The CCL7 protein is a ligand which binds to receptors 
such as CCR1, CCR2 and CCR3. The binding activates 
monocytes, lymphocytes, dendritic cells, NK cells, and 
granulocytes.(30) In line with CCL7 expression, we found 
that CCR1 and CCR3 gene expressions of the high responders 
also showed a trend of lower expression compared to low 
responders. CCR2 and its other ligand (i.e., CCL2), however, 
showed a significantly higher expression in low responders.
(31) This finding may indicate a synergistic role between 
CCL7 and its receptors in the pathogenesis of asthma. The 
RNA expression analysis from Mf BALf in this study are 
also limited to the airway response after 24 hours antigen 
challenge, which may not be relevant to the asthmatic lung 
or reflect the chronic aspect of asthma. 
 This study also suggests the likelihood that 
polymorphisms in the CCL7 gene promoter region are 
affect for gene expression of CCL7. Genetic variation in the 
promoter region allows for difference in transcription factors 
and such difference affect gene expression in respiratory 
tract muscles.(32) Our findings require further investigation 
to validate the use of CCL7 as a genetic marker to determine 
Mf reactivity to asthma-inducing allergens as a refined way 
to select for animals in a more efficient manner. 
 Information of CCL7 promoter haplotype may be 
a useful tool to identify Mf of certain asthma profile. Pre-
screening of animals using such information will allow for 
an efficient and more accurate selection of asthma model 
candidate, and eventually lead to less variation in animal 
response during the study. As of now, skin test using allergens 
remains as the tool for selection of hypersensitive Mf. This 
process involves injection of allergen in several sites on 
the skin performed under anaesthesia. The use of genetic 
marker to select Mf candidate for asthma study needs to be 
developed further as a refined approach to improve animal 
welfare. This follows the principles of 3Rs (reduction, 
refinement and replacement), which is an important aspect 
in every research that involves animals.(33,34) 
Conclusion
Polymorphism in CCL7 promoter region was associated 
with hyper-responsiveness of Mf to A. suum, and is therefore 
a potential genetic marker to support an efficient selection of 
Mf candidates for asthma study. 
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